Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Having a check-up appointment without receiving any type of scan is good, but also scares me. “Everything happens for a reason,” is among some of the unhelpful things you can say to someone with ...

It was a protein-based vaccine for follicular lymphoma that garnered positive results. "It was actually one of the first positive cancer vaccine positive trials in the field, but 15 years ago ...

Gilead already has a drug in the PI3K class approved approved in follicular lymphoma and chronic lymphocytic leukaemia. But Zydelig (idelalisib) has hit trouble after reports of serious side ...

The company, which operates a large facility in Limerick, was testing its experimental drug, odronextamab, in multiple late-stage trials in patients with follicular lymphoma and diffuse large B-cell ...

Top of the list is Ipsen/Epizyme’s selective EZH2 inhibitor Tazverik (tazemetostat), which has been approved in the US for relapsed or refractory follicular lymphoma patients with an EZH ...

Initiated Phase 1b dose expansion of NX-5948 in chronic lymphocytic leukemia patient population with Fast Track Designation from the FDAInitiated ...

Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...

It was a protein-based vaccine for follicular lymphoma that garnered positive results. “It was actually one of the first positive cancer vaccine positive trials in the field, but 15 years ago ...